How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

The family of 21-year NHL veteran Claude Lemieux is donating his brain to CTE research. The family announced in a statement that the four-time Stanley Cup champion's brain will be given to the UNITE ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

EDITOR’S NOTE: This story contains discussion of suicide. Claude Lemieux’s brain is being donated to the Boston University CTE Center to research the long-term effects of repetitive brain injuries, ...

Lemieux's family is donating his brain to the Boston University CTE Center for research into the effects of repetitive brain injuries. CTE is a degenerative brain disease found in people with a ...

Claude Lemieux’s brain is being donated to the Boston University CTE Center to research the long-term effects of repetitive brain injuries, his family said Saturday in a statement released by daughter ...

"No conclusions should be drawn at this time regarding any diagnosis," the family said in a statement. Claude Lemieux died this week at age 60. Michael Martin / NHLI via Getty Images Claude Lemieux’s ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.